| Net Cash Provided by (Used in) Operating Activities |
-113K |
USD |
+65.1% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
180K |
USD |
+60.8% |
Q2 2024 |
Q1 2026 |
| Common Stock, Shares Authorized |
500M |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
43.1M |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-113K |
USD |
+21.6% |
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
484 |
USD |
-99.9% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Valuation Allowance |
9.01M |
USD |
+11.2% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
8.08M |
USD |
+6.04% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q1 2025 |
FY 2025 |
| Additional Paid in Capital |
32.5M |
USD |
+2.6% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q2 2026 |
| Interest Expense |
411K |
USD |
+24.5% |
Q1 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |